Portuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectors

NCT01235455 · clinicaltrials.gov ↗

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Remitting Multiple Sclerosis (RRMS)
Secondary Progressive Multiple Sclerosis (SPMS)

Interventions

DRUG: Interferon beta-1b (Betaseron, BAY86-5046)

Sponsor

Bayer